Sudden Hearing Loss: AudioCure's Novel Compound AC102 Restores Hearing in Preclinical Models, Published in PNAS
BERLIN--(BUSINESS WIRE)--Apr 1, 2024--
Source: eagletribune.com
Stay updated with breaking news from Audiocure Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
BERLIN--(BUSINESS WIRE)--Apr 1, 2024--
A single application of the novel compound AC102 almost completely restores noise-induced hearing loss in preclinical models.
BERLIN--(BUSINESS WIRE)--Mar 12, 2024--
BERLIN, December 07, 2023--AudioCure's AC102 receives Hearing Technology Innovator Award for groundbreaking hearing loss treatment. A pan-European Phase 2 trial is ongoing.